~~<i id='52F3868EB6'><strike id='52F3868EB6'><tt id='52F3868EB6'><pre id='52F3868EB6'></pre></tt></strike></i>~~

Home» focus» leisure time

leisure time

author：knowledge 2025-10-06 15:01:45 Page View：9

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bryan Kohberger seeks indictment dismissal in Idaho college killings case
Next article： Moonlake's readout produced a cash windfall. Risks remain

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

With psoriasis trial ahead, Alumis raises $259 million

Aclose-upofpsoriasisonahand.AdobeSanFranciscostartupAlumisInc.hasraised$259millioninabidtobestbigpha

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

The problem with charging patients to message their doctors

AdobeThinkingaboutmessagingyourphysicianaboutaweirdrash?Youmaywanttoholdoffonit.Somehospitalsystemsh